Ambien & FDA Approval

The branded Ambien® medicine, a product of the pharmaceutical company Sanofi-Aventis, has been granted initial US approval by the FDA (Food and Drugs Administration) in 1992 as an effective treatment for insomnia in adults. However, the generic name of Ambien® is Zolpidem tartrate and the FDA has also approved Generic 5 and 10 mg Zolpidem Tartrate (Ambien) tablets manufactured by specific pharmaceutical companies. These generic manufacturers are namely,

  • SYNTHON PHARMACEUTICALS, INC.
  • APOTEX INC.
  • RANBAXY LABORATORIES LIMITED
  • DR. REDDY’S LABORATORIES LTD
  • MYLAN PHARMACEUTICALS, INC.
  • ROXANE LABORATORIES, INC.
  • WATSON LABORATORIES, INC.
  • PAR PHARMACEUTICAL, INC.
  • CARLABAD TECHNOLOGY, INC.
  • GENPHARM INC
  • MUTUAL PHARMACEUTICAL COMPANY, INC.
  • CARACO PHARMACEUTICAL LABORATOTRIES, LTD
  • LEK PHARMACEUTICALS, d.d.
  • TEVA PHARMACEUTICALS USA

Ambien® has been approved by the FDA after evaluating the effectiveness of this medicine through a whole range of clinical experiments. The series of clinical trials undertaken on Ambien have made it evident that soon after the administration of Ambien, the medicine starts functioning on certain chemicals present in the brain that are responsible for causing insomnia and relieves people from the clasp of sleeplessness. Therefore, without any hesitation, you can administer Ambien and obtain relief from the grip of insomnia.